Study Determines Impact of Controlled Substance Safety Committee
Mechelle Sanders, PhD
The goal of the study of the Controlled Substance Safety Committee (CSSC) is to describe and understand the implementation of the multidisciplinary committee at Highland Family Medicine and determine its impact on clinical decision-making and patient outcomes. The design of the study is an Explanatory Mixed-methods (quantitative and qualitative), according to Mechelle Sanders, Ph.D. The quantitative part involves a retrospective review of EHR data for patients on the CSSC registry to explore any controlled substance related medication treatment changes they may have had between 2017-2021. The qualitative part involves semi-structured interviews with HFM clinicians to understand their experience with the CSSC in supporting their treatment strategies with patients on controlled substances.
Medical students, staff and faculty are working together on several research projects:
- Examining opioid dose reductions by sex and race in a cohort of patients in a Family Medicine training practice.
- Improving Opioid Safety Practices in Primary Care: Implementation lessons from a multidisciplinary Controlled Substance Safety Committee
- Impact of 2016 and 2022 CDC guidelines on Opioid Stewardship in Primary Care
4/2/2023
You may also like